Banerjee, D., Boboila, S., Okochi, S., Angelastro, J. M., Kadenhe-Chiweshe, A. V., Lopez, G., Califano, A., Connolly, E. P., Greene, L. A., & Yamashiro, D. J. (2023). Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis Resistance. Cancer Research Communications, 3(12), 2518–2530. https://doi.org/10.1158/2767-9764.crc-23-0154

Stokes, M. E., Vasciaveo, A., Small, J. C., Zask, A., Reznik, E., Smith, N., Wang, Q., Daniels, J., Forouhar, F., Rajbhandari, P., Califano, A., & Stockwell, B. R. (2024). Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers. Cell Chemical Biology, 31(4), 805-819.e9. https://doi.org/10.1016/j.chembiol.2023.11.007

Qureshi, N., Orimoloye, H., Hansen, J., Saechao, C., Olsen, J., Federman, N., Huang, X., He, D., Ritz, B., & Heck, J. E. (2023). Maternal anemia and childhood cancer: a population-based case-control study in Denmark. Cancer Epidemiology, 82, 102308. https://doi.org/10.1016/j.canep.2022.102308

Cheng, F., Zheng, W., Barbuti, P. A., Bonsi, P., Liu, C., Casadei, N., Ponterio, G., Meringolo, M., Admard, J., Dording, C. M., Yu-Taeger, L., Nguyen, H. P., Grundmann-Hauser, K., Ott, T., Houlden, H., Pisani, A., Krüger, R., & Riess, O. (2022). DYT6 mutated THAP1 is a cell type dependent regulator of the SP1 family. Brain, 145(11), 3968–3984. https://doi.org/10.1093/brain/awac001

Çoku, J., Booth, D. M., Skoda, J., Pedrotty, M. C., Vogel, J., Liu, K., Vu, A., Carpenter, E. L., Ye, J. C., Chen, M. A., Dunbar, P., Scadden, E., Yun, T. D., Nakamaru‐Ogiso, E., Area‐Gomez, E., Li, Y., Goldsmith, K. C., Reynolds, C. P., Hajnoczky, G., & Hogarty, M. D. (2022). Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance. The EMBO Journal, 41(8). Portico. https://doi.org/10.15252/embj.2021108272